查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1941475

人工智慧基因组学市场规模、份额和趋势分析报告：按组件、技术、功能、应用、最终用途、地区和细分市场预测（2026-2033 年）

AI In Genomics Market Size, Share & Trends Analysis Report By Component (Hardware, Software), By Technology (Machine Learning), By Functionality (Genome Sequencing, Gene Editing), By Application, By End Use, By Region, And Segment Forecasts 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

基因组学领域的人工智慧市场概览

全球基因组学人工智慧市场预计到 2025 年将达到 12.6 亿美元，到 2033 年将达到 188.2 亿美元。

预计从 2026 年到 2033 年，该市场将以 40.30% 的复合年增长率成长。基因组数据量的不断增加、对精准医疗日益增长的需求以及药物发现和开发的加速是市场成长背后的主要因素。

此外，技术进步和产业合作正在强化市场环境。新一代定序技术的快速发展显着增加了基因组资料集的规模和复杂性。全基因组分析和多体学研究产生的数据量已超越传统生物资讯工具的处理能力。例如，美国国家人类基因组实验室预测，未来十年基因组研究将产生2至40Exabyte的数据。然而，人工智慧能够对这些大型资料集进行可扩展的处理、解读和整合。数据量的快速增长使得人工智慧对于基因组研究和临床应用至关重要。这种结构性变化正在大力推动人工智慧在基因组学领域的应用。

此外，精准医疗需求的不断增长进一步推动了市场成长。基因组分析的洞见对于识别患者特异性疾病风险和预测治疗反应至关重要。人工智慧有助于大规模解读复杂的基因型-表现型关係。精准肿瘤学、罕见疾病诊断和药物基因组学正日益依赖人工智慧驱动的基因组学。此外，与临床数据的整合能够改善实际决策。例如，在2025年11月举行的AMP年会上，Complete Genomics和SOPHiA GENETICS合作，将IMSK-IMPACT和MSK-ACCESS与SOPHiA DDM整合到DNBSEQ-T1+定序仪上，从而实现了端到端的人工智慧驱动的癌症基因组分析。

目录

第一章调查方法和范围

第二章执行摘要

3. 基因组学领域人工智慧市场变数、趋势和范围

  • 市场谱系展望
    • 母市场展望
    • 相关及辅助市场展望
  • 市场动态
  • 基因组学领域的人工智慧市场分析工具
    • 产业分析：波特五力模型
    • PESTEL 分析

第四章 基因组学人工智慧市场（一）：按组件分類的估算与趋势分析

  • 全球基因组学人工智慧市场成分波动分析
  • 全球基因组学人工智慧市场规模及趋势分析（按组件划分）（2021-2033 年）
  • 软体
  • 硬体
  • 服务

第五章 基因组学领域的人工智慧市场：按技术、估算和趋势分析

  • 全球人工智慧基因组学市场技术变革分析
  • 全球人工智慧基因体学市场规模及趋势分析（按技术划分）（2021-2033 年）
  • 机器学习演算法
    • 深度学习
    • 和老师
    • 无人监管
    • 其他的
  • 电脑视觉

第六章 基因组学领域的人工智慧市场：按功能、估算和趋势分析

  • 全球基因组学人工智慧市场功能波动分析
  • 全球基因组学人工智慧市场规模及趋势分析（按功能划分）（2021-2033 年）
  • 基因组定序
  • 基因编辑
    • 其他的

第七章 基因组学领域的人工智慧市场：应用、估算与趋势分析

  • 全球基因组学人工智慧市场变化分析
  • 全球基因体学人工智慧市场规模及应用趋势分析（2021-2033）
  • 药物发现与开发
  • 精准医疗
  • 诊断
  • 其他应用领域

8. 基因组学人工智慧市场：按最终用途分類的预测和趋势分析

  • 全球基因组学人工智慧市场终端用途差异分析
  • 全球基因组学人工智慧市场规模及趋势分析（按最终用途划分）（2021-2033 年）
  • 製药和生物技术公司
  • 医疗保健提供者
  • 研究中心
  • 其他的

9. 基因组学人工智慧市场：区域、估算和趋势分析

  • 2025年及2033年区域市占率分析
  • 区域市场概览
  • 市场规模及预测趋势分析，2021-2033年
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 公司/竞争对手分类
  • 策略规划
  • 2025年商业市场分析
  • 公司简介/列表
    • Microsoft Corporation
    • NVIDIA Corporation
    • DEEP GENOMICS
    • Data4Cure, Inc.
    • Freenome Holdings, Inc.
    • Thermo Fisher Scientific
    • Illumina, Inc.
    • SOPHiA GENETICS
    • BenevolentAI
    • Fabric Genomics
Product Code: GVR-4-68040-037-9

AI In Genomics Market Summary

The global AI in genomics market size was valued at USD 1.26 billion in 2025 and is projected to reach USD 18.82 billion by 2033, growing at a CAGR of 40.30% from 2026 to 2033. The growing volume of genomic data, the rising demand for precision medicine, and the acceleration of drug discovery & development are significant factors contributing to market growth.

Moreover, technological advancements and industry partnerships are strengthening the market environment. Rapid advances in next-generation sequencing have significantly increased the volume and complexity of genomic datasets. Whole-genome and multi-omics studies generate data that exceed the capacity of traditional bioinformatics tools. For instance, the National Human Genome Research Institute predicts that genomics research is expected to generate between 2 and 40 exabytes of data within the next decade. However, AI enables scalable processing, interpretation, and integration of these large datasets. The growing intensity of data makes AI essential for genomic research and clinical applications. This structural shift strongly drives AI adoption in genomics.

Moreover, the increasing demand for precision medicine further drives market growth. Genomic insights are crucial for identifying patient-specific disease risks and predicting therapy responses. AI supports the interpretation of complex genotype-phenotype relationships at scale. Precision oncology, rare disease diagnostics, and pharmacogenomics increasingly rely on AI-enabled genomics. In addition, integration with clinical data improves actionable decision-making. For instance, in November 2025, Complete Genomics and SOPHiA GENETICS collaborated at the AMP Annual Meeting to integrate IMSK-IMPACT and MSK-ACCESS, powered by SOPHiA DDM, onto the DNBSEQ-T1+ sequencer, delivering end-to-end, AI-driven cancer genomic profiling.

Global AI in Genomics Market Report Segmentation

This report forecasts, revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented global AI in genomics market report based on component, technology, functionality, application, end use, and region.

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • Hardware
  • Service
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Machine Learning (ML)
    • Deep Learning
    • Supervised Learning
    • Unsupervised Learning
    • Others
  • Computer Vision
  • Functionality Outlook (Revenue, USD Million, 2021 - 2033)
  • Genome Sequencing
  • Gene Editing
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Discovery & Development
  • Precision Medicine
  • Diagnostics
  • Other Applications
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical and Biotech Companies
  • Healthcare Providers
  • Research Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Component Segment
    • 1.2.2. Technology Segment
    • 1.2.3. Functionality Segment
    • 1.2.4. Application Segment
    • 1.2.5. End Use
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. AI in Genomics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. AI in Genomics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape

Chapter 4. AI in Genomics Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global AI in Genomics Market Component Movement Analysis
  • 4.3. Global AI in Genomics Market Size & Trend Analysis, by Component, 2021 to 2033 (USD Million)
  • 4.4. Software
    • 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5. Hardware
    • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6. Services
    • 4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. AI in Genomics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global AI in Genomics Market Technology Movement Analysis
  • 5.3. Global AI in Genomics Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 5.4. Machine Learning Algorithms
    • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 5.4.2. Deep learning
      • 5.4.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 5.4.3. Supervised
      • 5.4.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 5.4.4. Unsupervised
      • 5.4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 5.4.5. Others
      • 5.4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.5. Computer Vision
    • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. AI in Genomics Market: Functionality Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global AI in Genomics Market Functionality Movement Analysis
  • 6.3. Global AI in Genomics Market Size & Trend Analysis, by Functionality, 2021 to 2033 (USD Million)
  • 6.4. Genome Sequencing
    • 6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5. Gene Editing
    • 6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.2. Others
    • 6.5.3. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. AI in Genomics Market: Application Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global AI in Genomics Market Application Movement Analysis
  • 7.3. Global AI in Genomics Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 7.4. Drug Discovery & Development
    • 7.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5. Precision Medicine
    • 7.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.6. Diagnostics
    • 7.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7. Other Applications
    • 7.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. AI in Genomics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global AI in Genomics Market End Use Movement Analysis
  • 8.3. Global AI in Genomics Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 8.4. Pharmaceutical and Biotech Companies
    • 8.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5. Healthcare Providers
    • 8.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.6. Research Centers
    • 8.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.7. Others
    • 8.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 9. AI in Genomics Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2025 & 2033
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 9.4. North America
    • 9.4.1. U.S.
      • 9.4.1.1. Key country dynamics
      • 9.4.1.2. Regulatory framework
      • 9.4.1.3. Competitive scenario
      • 9.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.4.2. Canada
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework
      • 9.4.2.3. Competitive scenario
      • 9.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.4.3. Mexico
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework
      • 9.4.3.3. Competitive scenario
      • 9.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.5. Europe
    • 9.5.1. UK
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.5.2. Germany
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.5.3. France
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.5.4. Italy
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.5.5. Spain
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework
      • 9.5.5.3. Competitive scenario
      • 9.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.5.6. Norway
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework
      • 9.5.6.3. Competitive scenario
      • 9.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.5.7. Sweden
      • 9.5.7.1. Key country dynamics
      • 9.5.7.2. Regulatory framework
      • 9.5.7.3. Competitive scenario
      • 9.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.5.8. Denmark
      • 9.5.8.1. Key country dynamics
      • 9.5.8.2. Regulatory framework
      • 9.5.8.3. Competitive scenario
      • 9.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Japan
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.6.2. China
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.6.3. India
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.6.4. Australia
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework
      • 9.6.4.3. Competitive scenario
      • 9.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.6.5. South Korea
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.6.6. Thailand
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Regulatory framework
      • 9.6.6.3. Competitive scenario
      • 9.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Brazil
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.7.2. Argentina
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.8. MEA
    • 9.8.1. South Africa
      • 9.8.1.1. Key country dynamics
      • 9.8.1.2. Regulatory framework
      • 9.8.1.3. Competitive scenario
      • 9.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.8.2. Saudi Arabia
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework
      • 9.8.2.3. Competitive scenario
      • 9.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.8.3. UAE
      • 9.8.3.1. Key country dynamics
      • 9.8.3.2. Regulatory framework
      • 9.8.3.3. Competitive scenario
      • 9.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.8.4. Kuwait
      • 9.8.4.1. Key country dynamics
      • 9.8.4.2. Regulatory framework
      • 9.8.4.3. Competitive scenario
      • 9.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2025
  • 10.4. Company Profiles/Listing
    • 10.4.1. Microsoft Corporation
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. NVIDIA Corporation
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. DEEP GENOMICS
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Data4Cure, Inc.
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Freenome Holdings, Inc.
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. Thermo Fisher Scientific
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Illumina, Inc.
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. SOPHiA GENETICS
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. BenevolentAI
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. Fabric Genomics
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global AI in genomics market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 4 Global AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 5 Global AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 6 Global AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 7 Global AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 8 North America AI in genomics market, by country, 2021 - 2033 (USD Million)
  • Table 9 North America AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 10 North America AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 11 North America AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 12 North America AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 13 North America AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 14 U.S. AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 15 U.S. AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 16 U.S. AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 17 U.S. AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 18 U.S. AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Canada AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 20 Canada AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 21 Canada AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 22 Canada AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 23 Canada AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Mexico AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 25 Mexico AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 26 Mexico AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 27 Mexico AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 28 Mexico AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 29 Europe AI in genomics market, by country, 2021 - 2033 (USD Million)
  • Table 30 Europe AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 31 Europe AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 32 Europe AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 33 Europe AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 34 Europe AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 35 UK AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 36 UK AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 37 UK AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 38 UK AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 39 UK AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 40 Germany AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 41 Germany AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 42 Germany AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 43 Germany AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 44 Germany AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 45 France AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 46 France AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 47 France AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 48 France AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 49 France AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 50 Italy AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 51 Italy AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 52 Italy AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 53 Italy AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 54 Italy AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 55 Spain AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 56 Spain AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 57 Spain AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 58 Spain AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 59 Spain AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 60 Denmark AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 61 Denmark AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 62 Denmark AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 63 Denmark AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 64 Denmark AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 65 Sweden AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 66 Sweden AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 67 Sweden AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 68 Sweden AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 69 Sweden AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 70 Norway AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 71 Norway AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 72 Norway AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 73 Norway AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 74 Norway AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 75 Asia Pacific AI in genomics market, by country, 2021 - 2033 (USD Million)
  • Table 76 Asia Pacific AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 77 Asia Pacific AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 78 Asia Pacific AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 79 Asia Pacific AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 80 Asia Pacific AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 81 China AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 82 China AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 83 China AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 84 China AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 85 China AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Japan AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 87 Japan AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 88 Japan AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 89 Japan AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 90 Japan AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 91 India AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 92 India AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 93 India AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 94 India AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 95 India AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 96 South Korea AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 97 South Korea AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 98 South Korea AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 99 South Korea AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 100 South Korea AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 101 Australia AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 102 Australia AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 103 Australia AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 104 Australia AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 105 Australia AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 106 Thailand AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 107 Thailand AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 108 Thailand AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 109 Thailand AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 110 Thailand AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 111 Latin America AI in genomics market, by country, 2021 - 2033 (USD Million)
  • Table 112 Latin America AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 113 Latin America AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 114 Latin America AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 115 Latin America AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 116 Latin America AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 117 Brazil AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 118 Brazil AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 119 Brazil AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 120 Brazil AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 121 Brazil AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 122 Argentina AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 123 Argentina AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 124 Argentina AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 125 Argentina AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 126 Argentina AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 127 MEA AI in genomics market, by country, 2021 - 2033 (USD Million)
  • Table 128 MEA AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 129 MEA AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 130 MEA AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 131 MEA AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 132 MEA AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 133 South Africa AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 134 South Africa AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 135 South Africa AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 136 South Africa AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 137 South Africa AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 138 Saudi Arabia AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 139 Saudi Arabia AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 140 Saudi Arabia AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 141 Saudi Arabia AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 142 Saudi Arabia AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 143 UAE AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 144 UAE AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 145 UAE AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 146 UAE AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 147 UAE AI in genomics market, by end use, 2021 - 2033 (USD Million)
  • Table 148 Kuwait AI in genomics market, by component, 2021 - 2033 (USD Million)
  • Table 149 Kuwait AI in genomics market, by application, 2021 - 2033 (USD Million)
  • Table 150 Kuwait AI in genomics market, by functionality, 2021 - 2033 (USD Million)
  • Table 151 Kuwait AI in genomics market, by technology, 2021 - 2033 (USD Million)
  • Table 152 Kuwait AI in genomics market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Market formulation & validation
  • Fig. 5 AI in genomics market: Market outlook
  • Fig. 6 AI in genomics market: Segment outlook
  • Fig. 7 AI in genomics market: Competitive landscape outlook
  • Fig. 8 Parent market outlook
  • Fig. 9 AI in genomics market driver impact
  • Fig. 10 AI in genomics market restraint impact
  • Fig. 11 AI in genomics market: Component outlook and key takeaways
  • Fig. 12 AI in genomics market: Component movement analysis
  • Fig. 13 Software market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 14 Hardware market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 15 Service market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 16 AI in genomics market: Technology outlook and key takeaways
  • Fig. 17 AI in genomics market: Technology movement analysis
  • Fig. 18 Machine learning algorithms market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Deep learning market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Supervised market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Unsupervised market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Others neural networks market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Computer vision market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 AI in genomics market: Functionality outlook and key takeaways
  • Fig. 25 AI in genomics market: Functionality movement analysis
  • Fig. 26 Genome sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Others neural networks market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 AI in genomics market: Application outlook and key takeaways
  • Fig. 30 AI in genomics market: Application movement analysis
  • Fig. 31 Drug discovery & development market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Precision medicine market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Other applications market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 AI in genomics market: End use outlook and key takeaways
  • Fig. 36 AI in genomics market: End use movement analysis
  • Fig. 37 Pharmaceutical and biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Healthcare providers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Research centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Global AI in genomics market: Regional outlook and key takeaways
  • Fig. 42 Global AI in genomics market: Regional movement analysis
  • Fig. 43 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 U.S. key country dynamics
  • Fig. 45 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Canada key country dynamics
  • Fig. 47 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Mexico key country dynamics
  • Fig. 49 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 UK key country dynamics
  • Fig. 52 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Germany key country dynamics
  • Fig. 54 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 France key country dynamics
  • Fig. 56 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Italy key country dynamics
  • Fig. 58 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Spain key country dynamics
  • Fig. 60 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Denmark key country dynamics
  • Fig. 62 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Sweden key country dynamics
  • Fig. 64 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Norway key country dynamics
  • Fig. 66 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Japan key country dynamics
  • Fig. 69 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 China key country dynamics
  • Fig. 71 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 India key country dynamics
  • Fig. 73 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Thailand key country dynamics
  • Fig. 75 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 South Korea key country dynamics
  • Fig. 77 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Australia key country dynamics
  • Fig. 79 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Brazil key country dynamics
  • Fig. 82 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Argentina key country dynamics
  • Fig. 84 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 South Africa key country dynamics
  • Fig. 87 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Saudi Arabia key country dynamics
  • Fig. 89 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 UAE key country dynamics
  • Fig. 91 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Kuwait key country dynamics
  • Fig. 93 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)